05 February 2022 | News
For introducing Corbevax vaccine in augmenting the global collective fight against COVID-19
Federation of Asian Biotech Associations [FABA] has announced the recipients of this year’s prestigious FABA Awards, which was named after Dr. B. S Bajaj last year, for their contributions to the advancement in Biotechnology. The Executive Council of FABA, which met on 11.1.2022 announced the FABA Awards for the year 2022.
Dr. B. S. Bajaj Memorial FABA Special Award-2022 will be conferred upon Mahima Datla, Managing Director, Biological E. Ltd for introducing Corbevax vaccine in augmenting the global collective fight against COVID-19. The award will be conferred during the 19th edition of BioAsia, the largest annual global Biotechnology and Life Sciences summit of Asia, organised by the Government of Telangana and FABA.
Biological E. Limited (BE), one of the world’s largest vaccine manufacturers, was recognized for the development of CORBEVAX-TM, India’s first indigenously developed protein sub-unit vaccine against COVID-19. CORBEVAX-TM is a recombinant vaccine, developed from the receptor binding domain (RBD) of the spike protein on the virus’s surface combined with Dynavax’s CpG 1018 adjuvant with alum, which helps the body build the immune response against the virus.